Biotech · Private company
R-Pharm Overseas, Inc.
Track this companyFree. Adds R-Pharm Overseas, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- RPH-104Phase 3 · Recurrent PericarditisClinicalTrials.gov · fetched Nov 12, 2026
- 80 mg RPH-104Phase 2 · Schnitzler SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- RPH-104 80 mgPhase 2 · Acute ST Segment Elevation Myocardial InfarctionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent PericarditisPHASE2_PHASE3 · SUSPENDED · started Dec 1, 2025ClinicalTrials.gov NCT05107934 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler SyndromePHASE2 · WITHDRAWN · started May 1, 2023ClinicalTrials.gov NCT04213274 · fetched Nov 12, 2026
- Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial InfarctionPHASE2 · COMPLETED · started Dec 7, 2020ClinicalTrials.gov NCT04463251 · fetched Nov 12, 2026